Evolent Health, Inc.
EVH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62 | -$113 | -$19 | -$38 |
| Dep. & Amort. | $126 | $123 | $67 | $60 |
| Deferred Tax | -$3 | -$31 | $0 | -$1 |
| Stock-Based Comp. | $40 | $41 | $34 | $17 |
| Change in WC | -$117 | $22 | -$104 | -$22 |
| Other Non-Cash | $34 | $101 | $11 | $23 |
| Operating Cash Flow | $19 | $143 | -$12 | $39 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$25 | -$29 | -$38 | -$25 |
| Net Acquisitions | $0 | $1 | $6 | $14 |
| Inv. Purchases | -$7 | $0 | -$6 | -$3 |
| Inv. Sales/Matur. | $0 | $0 | $6 | $1 |
| Other Inv. Act. | -$31 | -$388 | -$226 | -$3 |
| Investing Cash Flow | -$63 | -$416 | -$259 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $59 | $183 | $220 | -$38 |
| Stock Issued | $3 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$18 | $0 |
| Dividends Paid | -$20 | -$19 | $0 | -$1 |
| Other Fin. Act. | -$43 | $117 | -$70 | $9 |
| Financing Cash Flow | -$1 | $281 | $132 | -$30 |
| Forex Effect | -$0 | -$0 | -$1 | -$0 |
| Net Chg. in Cash | -$45 | $8 | -$140 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $223 | $215 | $355 | $362 |
| End Cash | $178 | $223 | $215 | $355 |
| Free Cash Flow | -$6 | $114 | -$50 | $14 |